PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300 | -29.2% | 17,991 | +17.2% | 0.02% | -32.4% |
| Q2 2023 | $424 | +112.0% | 15,354 | +76.2% | 0.03% | +126.7% |
| Q1 2023 | $200 | +18.3% | 8,713 | -43.7% | 0.02% | +7.1% |
| Q4 2022 | $169 | -99.9% | 15,482 | -35.1% | 0.01% | -26.3% |
| Q3 2022 | $201,000 | -29.5% | 23,848 | -33.8% | 0.02% | -26.9% |
| Q2 2022 | $285,000 | +15.4% | 36,033 | +245.1% | 0.03% | +225.0% |
| Q1 2022 | $247,000 | – | 10,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |